Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: Involvement in tumor progression and metastasis

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 73-79

  Zhou, Chuan Xiang ^a   Gao, Yan ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Axin1; Denaturing high performance liquid chromatography; Differentiation; Immunohistochemistry; Metastasis; Mutation; Oral squamous cell carcinoma; Polymorphism

Indexed keywords

AXIN PROTEIN; DNA; REPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CODON; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CODON; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS;

EID: 34848850305     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.73     Document Type: Article

References (33)

1. Zeng L, Fagotto F, Zhang T, et al: The mouse Fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192, 1997. (Pubitemid 28009429)
2. Wodarz A and Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88, 1998. (Pubitemid 29001449)
3. Bienz M and Clever H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
4. Ikeda S, Kishida S, Yamamoto H, et al: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371-1384, 1998. (Pubitemid 28105516)
5. Kishida S, Yamamoto H, Ikeda S, et al: Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273: 10823-10826, 1998. (Pubitemid 28204914)
6. Heldin CH, Miyazono K and ten Dijke P: TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997. (Pubitemid 28013118)
7. Furuhashi M, Yagi K, Yamamoto H, et al: Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol 21: 5132-5141, 2001. (Pubitemid 32656409)
8. Nishita M, Hashimoto MK, Ogata S, et al: Interaction between Wnt and TGF-beta signaling pathways during formation of Spemann's organizer. Nature 403: 781-785, 2000. (Pubitemid 30111840)
9. Zhang Y, Neo SY, Han J, et al: Dimerization choices control the ability of axin and disheveled to activate c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem 275: 25008-25014, 2000. (Pubitemid 30626610)
10. Raybaud-Diogene H, Tetu B, Morency R, Fortin A and Monteil RA: P53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32: 143-149, 1996.
11. Taniguchi K, Roberts LR, Aderca IN, et al: Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastoma. Oncogene 21: 4863-4871, 2002. (Pubitemid 34879463)
12. Wu R, Zhai Y, Fearon ER, et al: Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61: 8247-8255, 2001. (Pubitemid 33091619)
13. Shimizu Y, Ikeda S, Fujimori M, et al: Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 33: 73-81, 2002.
14. Jin LH, Shao QJ, Luo W, et al: Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer 107: 696-699, 2003. (Pubitemid 37339721)
15. Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC and Lin CC: Correlation between protein expression and epigenetic and mutation changes of Wnt pathway genes in oral cancer. Int J Oncol 23: 1001-1007, 2003.
16. Iwai S, Katagiri W, Kong C, Amekawa S, Nakazawa M and Yura Y: Mutations of the APC, beta-catenin, and axin1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 131: 773-782, 2005. (Pubitemid 41630700)
17. Yamamoto H, Kishida S, Uochi T, et al: Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 18: 2867-2875, 1998. (Pubitemid 28183455)
18. Cong F and Varmus H: Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci USA 101: 2882-2887, 2004. (Pubitemid 38327705)
19. Mai M, Qian C, Yokomizo A, et al: Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. Genomics 55: 341-344, 1999.
20. Mao J, Wang J, Liu B, et al: Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809, 2001. (Pubitemid 32436440)
21. Tolwinski NS, Wehrli M, Rives A, et al: Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. Dev Cell 4: 407-418, 2003. (Pubitemid 36342365)
22. Behrens J, Jerchow BA, Wurtele M, et al: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599, 1998.
23. Li L, Yuan H, Weaver CD, et al: Axin and Frat1 interact with dvl and GSK, bridgingDvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 18: 4233-4240, 1999. (Pubitemid 29364125)
24. Kishida S, Yamamoto H, Hino S, et al: DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 19: 4414-4422, 1999. (Pubitemid 29242015)
25. Zhang Y, Neo SY, Wang X, et al: Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem 274: 35247-35254, 1999. (Pubitemid 129509583)
26. Zhang Y, Qiu WJ, Chan SC, et al: Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. J Biol Chem 277: 17706-17712, 2002. (Pubitemid 34967575)
27. Hsu W, Zeng L and Costantini F: Identification of a domain of axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274: 3439-3445, 1999. (Pubitemid 29077183)
28. Farr GH III, Ferkey DM, Yost C, et al: Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 148: 691-702, 2000.
29. Sakanaka C and Williams LT: Functional domains of axin. Importance of the C-terminus as an oligomerization domain. J Biol Chem 274: 14090-14093, 1999.
30. Rubinfeld B, Robbins P, El-Gamil M, et al: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
31. Uraguchi M, Moorikawa M, Shirakawa M, Sanada K and lmai K: Activation of Wnt family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 84: 327-332, 2004. (Pubitemid 41713770)
32. Amit S, Hatzubai A, Birman Y, et al: Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16: 1066-1076, 2002. (Pubitemid 34507196)
33. Satoh S, Daigo Y, Furukawa Y, et al: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genetics 24: 245-250, 2000. (Pubitemid 30132191)